kentucky glp-1 nausea lawyer vomiting class action kentucky glp-1 vomiting lawsuit Ozempic in Kentucky-150cent-mvanhaasteren.nl GLP-1 & Ozempic Lawsuit -

Description

The booming class of GLP-1 drugs that includes Ozempic and Wegovy is also showing early potential to help with Parkinsons disease, a new study suggests.

Here's what to know about investing in GLP-1 stocks.

Coverage Baseline Previously unavailable under Medicare Part D Only 13 states cover them in Medicaid (KFF HMA survey) 19% of large employers cover GLP-1s for obesity, though 43% of employers with 5,000+ employees offer coverage (KFF 2025 survey) Current Expansion ~50% of CVS Caremark clients now provide coverage for weight loss Medicare GLP-1 Bridge program launches coverage for eligible Medicare Part D patients 7/1/26 This aligns with a recent survey from Business Group on Health that found 67% of the surveyed employers now cover GLP-1s for weight loss (though a reduction is expected for 2027)

As a weight-loss tool, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are used in patients with obesity, which is a risk factor for cancers like colorectal and gastrointestinal